• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药剂师是罕见病患者姑息治疗的发起者。

Pharmacists are initiators in palliative care for patients with rare diseases.

机构信息

University Hospitals Leuven, Leuven, Belgium.

出版信息

Orphanet J Rare Dis. 2023 Jun 8;18(1):141. doi: 10.1186/s13023-023-02765-8.

DOI:10.1186/s13023-023-02765-8
PMID:37291601
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10249311/
Abstract

The World Health Organization supports early delivery of palliative care as it reduces unnecessary hospital admissions and the inappropriate use of health care services. A community pharmacist can play a key role in advocating timely access to palliative care. Medication reconciliation must alert them to start communicating with the patient and/or his relatives about refocusing treatment and care as part of palliative and terminal care. Pharmaceutical activities for these patients include dispensing of devices and medicinal products, compounding personalized medication and participating as a member of the Palliative Support Team. Most of the several thousands of rare diseases are caused by genetic defects and up to now have no cure and a late diagnosis.

摘要

世界卫生组织支持尽早提供姑息治疗,因为这可以减少不必要的住院和不适当的医疗服务使用。社区药剂师可以在倡导及时获得姑息治疗方面发挥关键作用。用药重整必须提醒他们开始与患者和/或他的亲属沟通,将治疗和护理重新聚焦作为姑息治疗和终末期护理的一部分。这些患者的药物治疗活动包括配药、配制个性化药物以及作为姑息治疗支持小组的成员参与。数千种罕见病中有大多数是由遗传缺陷引起的,到目前为止还没有治愈方法,而且诊断也较晚。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c5a/10249311/45fb30e9cdbe/13023_2023_2765_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c5a/10249311/45fb30e9cdbe/13023_2023_2765_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c5a/10249311/45fb30e9cdbe/13023_2023_2765_Fig1_HTML.jpg

相似文献

1
Pharmacists are initiators in palliative care for patients with rare diseases.药剂师是罕见病患者姑息治疗的发起者。
Orphanet J Rare Dis. 2023 Jun 8;18(1):141. doi: 10.1186/s13023-023-02765-8.
2
Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).POINT研究的设计:通过在基层医疗团队中纳入非配药药剂师实现药物治疗优化(POINT)。
BMC Fam Pract. 2015 Jul 2;16:76. doi: 10.1186/s12875-015-0296-8.
3
The oncology pharmacist as part of the palliative treatment team.肿瘤药师作为姑息治疗团队的一员。
Int J Pharm Pract. 2020 Feb;28(1):92-96. doi: 10.1111/ijpp.12583. Epub 2019 Oct 1.
4
Role of clinical pharmacist in the palliative care of adults and elderly patients with cancer: A scoping review.临床药师在成年及老年癌症患者姑息治疗中的作用:一项范围综述。
J Oncol Pharm Pract. 2022 Apr;28(3):664-685. doi: 10.1177/10781552211073470. Epub 2022 Jan 12.
5
A Specialist Palliative Pharmacist Enriches the Interdisciplinary Team: A Case Series Discussion Illustrating the Entrustable Professional Activities for Specialist Hospice and Palliative Care Pharmacists.专科姑息治疗药师丰富了多学科团队:一个案例系列讨论,阐述了专科临终关怀和姑息治疗药师的可委托专业活动。
J Palliat Med. 2023 Dec;26(12):1755-1758. doi: 10.1089/jpm.2023.0186. Epub 2023 Jun 26.
6
Introduction of pharmaceutical expertise in a palliative care team in Sweden.瑞典姑息治疗团队中药学专业知识的引入。
Pharm World Sci. 2010 Dec;32(6):829-34. doi: 10.1007/s11096-010-9450-5. Epub 2010 Oct 30.
7
Deprescribing Interventions by Palliative Care Clinical Pharmacists Surrounding Goals of Care Discussions.姑息治疗临床药师围绕护理目标讨论进行的减药干预措施。
J Palliat Med. 2022 Dec;25(12):1818-1823. doi: 10.1089/jpm.2021.0560. Epub 2022 Jun 14.
8
Evaluation of the effectiveness of UK community pharmacists' interventions in community palliative care.评估英国社区药剂师在社区姑息治疗中的干预效果。
Palliat Med. 2002 May;16(3):219-25. doi: 10.1191/0269216302pm533oa.
9
Medication management for community palliative care patients and the role of a specialist palliative care pharmacist: A qualitative exploration of consumer and health care professional perspectives.社区姑息治疗患者的药物管理和专科姑息治疗药剂师的作用:消费者和医疗保健专业人员观点的定性探讨。
Palliat Med. 2018 Sep;32(8):1369-1377. doi: 10.1177/0269216318777390. Epub 2018 May 25.
10
[Information transmission to the community pharmacist after a patient's discharge from the hospital: setting up of a written medication discharge form, prospective evaluation of its impact, and survey of the information needs of the pharmacists].[患者出院后向社区药剂师的信息传递:设立书面出院用药表单、对其影响的前瞻性评估以及药剂师信息需求调查]
J Pharm Belg. 2015 Mar(1):42-54.

引用本文的文献

1
The Community Pharmacy as a Study Center for the Epidemiological Analysis of the Population Vaccination against SARS-CoV-2: Evaluation of Vaccine Safety and Pharmaceutical Service.社区药房作为针对SARS-CoV-2人群疫苗接种进行流行病学分析的研究中心:疫苗安全性评估与药学服务
Pharmacy (Basel). 2024 Jan 20;12(1):16. doi: 10.3390/pharmacy12010016.

本文引用的文献

1
Palliative Care: A Primary Care Pharmacist Perspective.姑息治疗:初级保健药师视角
Pharmacy (Basel). 2022 Jul 13;10(4):81. doi: 10.3390/pharmacy10040081.
2
Palliative care in Duchenne muscular dystrophy: Goals of care discussions and beyond.杜氏肌营养不良症的姑息治疗:护理目标讨论及其他
Muscle Nerve. 2022 Jun;65(6):627-629. doi: 10.1002/mus.27544. Epub 2022 Apr 13.
3
Early Palliative Care in Acute Myeloid Leukemia.急性髓系白血病的早期姑息治疗
Cancers (Basel). 2022 Jan 18;14(3):478. doi: 10.3390/cancers14030478.
4
Role of clinical pharmacist in the palliative care of adults and elderly patients with cancer: A scoping review.临床药师在成年及老年癌症患者姑息治疗中的作用:一项范围综述。
J Oncol Pharm Pract. 2022 Apr;28(3):664-685. doi: 10.1177/10781552211073470. Epub 2022 Jan 12.
5
Understanding the Potential for Pharmacy Expertise in Palliative Care: The Value of Stakeholder Engagement in a Theoretically Driven Mapping Process for Research.了解药学专业知识在姑息治疗中的潜力:利益相关者参与理论驱动的研究映射过程的价值。
Pharmacy (Basel). 2021 Nov 26;9(4):192. doi: 10.3390/pharmacy9040192.
6
Patients with multiple myeloma referred for palliative care consultation: from retrospective analysis to future directions to improve clinical outcomes.多发性骨髓瘤患者接受姑息治疗咨询:从回顾性分析到改善临床结局的未来方向。
Support Care Cancer. 2022 Mar;30(3):2293-2298. doi: 10.1007/s00520-021-06560-8. Epub 2021 Oct 31.
7
End-of-use and end-of-life medicines-insights from pharmaceutical care process into waste medicines management.药品使用期限和寿命末期管理——从药学服务流程到废弃药品管理的深入了解。
Environ Sci Pollut Res Int. 2021 Nov;28(41):58170-58188. doi: 10.1007/s11356-021-14661-4. Epub 2021 Jun 9.
8
Impact of a specialised palliative care intervention in patients with advanced soft tissue sarcoma - a single-centre retrospective analysis.晚期软组织肉瘤患者接受专业姑息治疗干预的影响 - 单中心回顾性分析。
BMC Palliat Care. 2021 Jan 14;20(1):16. doi: 10.1186/s12904-020-00702-1.
9
Strategies for introducing palliative care in the management of relapsed or refractory aggressive lymphomas.复发或难治性侵袭性淋巴瘤的姑息治疗管理中的引入策略。
Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):148-153. doi: 10.1182/hematology.2020000100.
10
Opioid underuse in terminal care of long-term care facility residents with pain and/or dyspnoea: A cross-sectional PACE-survey in six European countries.长期护理机构中疼痛和/或呼吸困难的终末期患者阿片类药物使用不足:六个欧洲国家的 PACE 调查的横断面研究。
Palliat Med. 2020 Jun;34(6):784-794. doi: 10.1177/0269216320910332. Epub 2020 Apr 14.